Skip to main content
. 2017 Feb 21;10(1):25. doi: 10.3390/ph10010025

Figure 2.

Figure 2

Comparison of xenograft tumor volumes over time in anti-CK2 and control TBG nanocapsule treated mice. The changes in PC3-LN4 tumor volumes relative to day 0 are shown following three nanocapsule drug treatments. Nanocapsule doses were 0.01 mg/kg for anti-CK2 and F7 nanocapsules and 1 mg/kg for TBG-siCON1 nanocapsules. Means + standard error of the mean are presented. Group sizes TBG-RNAi-CK2 n = 9; TBG-RNAi-F7 n = 8; TBG-siCK2 n = 9. TBG-siCON1 n = 8. Arrows indicate days that nanocapsule treatment injections occurred. Statistical significance for day 10 is given in Table 1.